Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
about
H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccinesAdvances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccinesProtection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccinePreclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineConserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentModel answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planningCharacterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutininDevelopment and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity.Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant.Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.Detection and Isolation of Swine Influenza A Virus in Spiked Oral Fluid and Samples from Individually Housed, Experimentally Infected Pigs: Potential Role of Porcine Oral Fluid in Active Influenza A Virus Surveillance in Swine.H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.Assessing mathematical models of influenza infections using features of the immune response.Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.Evaluation of influenza-specific humoral response by microbead array analysisGenotype-specific vs. cross-reactive host immunity against a macroparasite.Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza virusesAge-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose.Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjectsSublingual vaccination with influenza virus protects mice against lethal viral infection.Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicityChronic spinal cord injury attenuates influenza virus-specific antiviral immunity.Epitope specificity of anti-HA2 antibodies induced in humans during influenza infectionInduction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults.Mouse models for the study of mucosal vaccination against otitis media.Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccinationInnate sensors of influenza virus: clues to developing better intranasal vaccines.Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
P2860
Q21090076-7EB8F383-C757-46F4-AE86-946B0C8C28CEQ27013568-C6809309-8862-42B2-9127-7D7CF733DB99Q27342511-3160E030-0E9E-4DA0-9BDD-2314F701FE88Q27347652-1CBB7756-5114-4F56-A7FD-2E4EEE2B6479Q30226873-CE77C82F-99D3-419A-938B-2BE5C6C8D24EQ30230076-016BBF88-725F-4545-8C5C-44163195B0AEQ30360436-227B5F74-2EE2-430C-A00B-A3E4229AC326Q30361736-DC5E2BD5-5D0E-416E-8175-614356DAD0E1Q30365079-1ACE62E9-4203-457E-9CA3-80E0C67070DAQ30366149-EE8AEFC7-2D5F-4BF7-8715-5B59591799BCQ30372481-2D7C64F7-A696-43CC-B182-2C67F9C12DBAQ30374752-C75A4962-3698-4943-BDE8-CEEF27F2ABE1Q30376369-EB7BB6B8-345C-4A1D-83A4-9C60026A2F66Q30379866-7CA4F8BE-917E-4D39-B66C-C5EA3684B9A6Q30382548-6E4B5358-F74E-4689-AE93-33649AD24419Q30382809-7FAFFC3F-2FD3-469B-96DC-EC71AEF280F9Q30388110-42F31D7D-A6B7-44F0-8256-D68E73CA12DBQ30390815-1716B511-F043-445B-A647-7B74D4C3AA7AQ30414515-75922A93-6D89-4AE6-A110-DDAB48DB5B72Q33447721-6944E720-8D0D-488E-8287-1B1978129A5AQ34105207-0B51D6F0-8439-4F44-8D2C-2FECAF7D436EQ34416904-F6668390-6F40-4F40-A3C4-962926DD680CQ34611749-0CD43005-3F2B-40DF-B126-7A1BD842CC4CQ34700580-506D4F70-F62A-40FD-96F5-0C1A5166A7E3Q34789793-B2E1C0BB-211C-4B24-BAA3-042A863DA427Q35027935-A7A0DA61-BA9D-4DE4-BDC9-BB98D8344952Q35038863-87ED0041-D3F1-4D2F-9C96-DC7391F45BACQ35575511-18E3AECA-2098-49D0-8E69-D154D9BB5F67Q35798811-D84039EE-FC14-4A2A-BAA3-91232759235CQ36239573-C3806EC1-7877-43F2-9192-BB033AA6CA55Q36295456-BF6996FF-1931-4247-9130-BFA840278805Q36446440-E730D9DA-03B7-4431-9259-66D687CAE3B1Q36540164-038967EB-FFE8-4010-A9A7-DB65696EBA24Q36950058-5B9EA25A-1084-418C-8F1C-A84CD261A52EQ37087170-582E9D58-DDD9-48D0-9B4D-62B6420BE6A7Q37087174-5D1BB6E4-5747-44D5-94B5-19F31DF01F5DQ37093093-06214702-408A-4896-B4F0-378998B8B9F6Q37157157-95CE74AB-79F0-4C9B-B7FB-F011A856DDABQ37298227-B45DB902-CED2-4BE7-B842-A3C598D6BBC6Q37452408-A3D403EA-1B59-4812-8446-07147C1A1AB4
P2860
Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mechanisms of broad cross-prot ...... their application to vaccines.
@ast
Mechanisms of broad cross-prot ...... their application to vaccines.
@en
type
label
Mechanisms of broad cross-prot ...... their application to vaccines.
@ast
Mechanisms of broad cross-prot ...... their application to vaccines.
@en
prefLabel
Mechanisms of broad cross-prot ...... their application to vaccines.
@ast
Mechanisms of broad cross-prot ...... their application to vaccines.
@en
P2093
P1476
Mechanisms of broad cross-prot ...... their application to vaccines
@en
P2093
Shin-ichi Tamura
Takeshi Kurata
Takeshi Tanimoto
P304
P577
2005-08-01T00:00:00Z